FIELD: pharmacology.
SUBSTANCE: invention relates to the use of dihydroquercetin as a diuretic, saluretic and creatininuretic agent.
EFFECT: invention makes it possible to increase the effectiveness of the therapeutic effect and exclude the occurrence of side effects.
9 cl, 1 dwg, 8 ex
| Title | Year | Author | Number |
|---|---|---|---|
| USE OF HYPEROZIDE AS A DIURETIC, SALURETIC AND CREATININURETIC AGENT | 2022 |
|
RU2802832C1 |
| USE OF QUERCETIN AS A DIURETIC, SALURETIC AND CREATININURETIC AGENT | 2022 |
|
RU2802833C1 |
| USE OF PINOSTROBIN AS DIURETIC AND CREATINURETIC AGENT | 2023 |
|
RU2816948C1 |
| USE OF PINOCEMBRIN AS DIURETIC AND CREATININURETIC AGENT | 2023 |
|
RU2822937C1 |
| USE OF OREGANOL A WITH DIURETIC ACTIVITY | 2022 |
|
RU2802873C1 |
| COMBINED MEDICATION FOR TREATMENT OF ARTERIAL HYPERTENSION IN PATIENTS WITH DIABETES MELLITUS | 2012 |
|
RU2558099C2 |
| USE OF PATULITRIN AS A DIURETIC | 2022 |
|
RU2807938C1 |
| PROCESS FOR PREPARATION OF A SUBSTANCE HAVING A DIURETIC ACTIVITY | 2017 |
|
RU2671408C1 |
| FRESH HAWTHORN FRUIT JUICE WITH DIURETIC ACTIVITY | 2019 |
|
RU2698325C1 |
| USE OF OREGANOL A WITH NEUROTROPIC ACTIVITY | 2022 |
|
RU2802871C1 |
